Pharmacist’s Letter | Clinical Updates, CE & Recommendations You Can Trust

Current Issue

January 2026 Issue

Address New GLP-1 Agonist Side Effect Concerns

Patients are asking if recent side effect claims with GLP-1 agonists (semaglutide, etc) are true...

Resources

Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Chart: Treatment and Prevention of Hair Loss
FAQ: Managing Erectile Dysfunction
Chart: Perioperative Management of Diabetes

Point Out Caveats With Direct-to-Consumer Meds

More drug companies and third-party platforms are selling Rx meds directly to patients...

Elinzanetant: Emerging Therapy for Menopausal Hot Flashes

Rx elinzanetant (Lynkuet) is now approved and adds a new nonhormonal option to the menopausal hot flash management toolbox...

Weave AI Into Your Plan for Precepting Learners

Preceptors are asking for advice on how to use artificial intelligence (AI) during learning experiences with residents and students...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Natural Medicines for Management of Type 2 Diabetes

CE IN THE LETTER: Pharmacist's Letter January 2026

LIVE CE: Pharmacy Essential Updates January 2026

PODCAST CE: Rumor vs Truth - GLP-1 Side Effects

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Free CE for Pharmacists

Pharmacist's Letter offers ACPE-accredited CE at no charge to help pharmacists meet license renewal requirements. Claim your free CE now:

Group Purchases & Pricing

Pharmacist’s Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information